What is Wilms tumour?

Last medical review:

Wilms tumour starts in immature kidney cells. A cancerous (malignant) tumour is a group of cancer cells that can grow into nearby tissue and destroy it. The tumour can also spread (metastasize) to other parts of the body. Wilms tumour is also called nephroblastoma.

The kidney is part of the urinary system. There are 2 kidneys, one on either side of the spine, deep inside the upper part of the abdomen. At the top of each kidney is an adrenal gland. The kidneys make urine (pee) by filtering water and waste from the blood.

Diagram of the location of the kidneys
Diagram of the location of the kidneys

During pregnancy, the kidneys are some of the first organs to develop in a fetus. Cells called nephroblasts grow and divide quickly to create the kidneys. At a certain point, the nephroblasts stop growing and dividing and they mature into kidney cells. But sometimes nephroblasts continue to grow out of control instead of maturing into kidney cells. These abnormal nephroblasts may lead to non-cancerous (benign) tumours such as congenital mesoblastic nephroma, which develops in newborns and infants.

In some cases, the abnormal nephroblasts can cause precancerous changes called nephrogenic rests. Nephrogenic rests are groups of abnormal kidney cells that may grow in many areas of the kidney or make a thick layer around the kidney. When this happens, the precancerous condition is called nephroblastomatosis. Nephroblastomatosis usually occurs in both kidneys and may become cancer, called Wilms tumour, if left untreated.

Wilms tumour is the most common type of kidney cancer in children. Itʼs usually diagnosed in children 2 to 4 years old.

Most Wilms tumours are found in only one kidney (called unilateral Wilms tumour). In about 5% of cases, it is found in both kidneys (called bilateral Wilms tumour). It may be in both kidneys at the time of diagnosis, or it may develop in the other kidney a few years after being found in the first kidney. Bilateral Wilms tumour is more common in children who have an inherited condition that increases the risk of Wilms tumour, such as Beckwith-Wiedemann syndrome or WAGR syndrome.

Types of Wilms tumour

There are 2 types of Wilms tumour, and each type is determined by how the cells look under a microscope (called histology). Doctors tell the 2 types apart based on whether anaplasia is present. Anaplasia is a loss of differentiation in the cells, which means they donʼt look or act like normal cells.

Favourable histology

About 90% to 95% of Wilms tumours are classified as having a favourable histology, which means there is no anaplasia present.

Wilms tumours with a favourable histology respond better to chemotherapy, so they have a better prognosis (outcome) than tumours with anaplasia present (anaplastic histology).

Anaplastic histology

About 5% to 10% of Wilms tumours are classified as having an anaplastic histology. An anaplastic histology may also be called an unfavourable histology. The cells in these tumours look very different from normal kidney cells and divide abnormally.

Anaplasia may be focal or diffuse.

Focal anaplasia means anaplasia is found only in one or a few specific areas of the tumour. The rest of the tumour looks like a regular (favourable histology) Wilms tumour.

Diffuse anaplasia means anaplasia is spread throughout the tumour.

Anaplastic tumours are more difficult to treat because they tend to be more resistant to chemotherapy. Anaplastic tumours are more likely to recur (come back) after treatment than tumours with a favourable histology.

Expert review and references

  • Meghan Pike, MD, FRCPC
  • American Cancer Society. Wilms Tumor. 2025. https://www.cancer.org/.
  • Cancer Research UK. Wilms Tumour (Nephroblastoma). 2023. https://www.cancerresearchuk.org/.
  • Fernandez CV, Geller JI, Ehrlich PF, et al. Renal tumors. Blaney SM, Adamson PC, Helman LJ (eds.). Pizzo and Pollack's Pediatric Oncology. 8th ed. Wolters Kluwer; 2021: Kindle version, [chapter 24] https://read.amazon.ca/?asin=B08DVWZNVP&language=en-CA.
  • Leslie SW, Sajjad H, Murphy PB. Wilms tumor. StatPearls [Internet]. StatPearls Publishing; 2023. https://www.statpearls.com/.
  • National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology: Wilms Tumor (Nephroblastoma) Version 2.2025. 2025. https://www.nccn.org/home.
  • Paulino AC. Medscape Reference: Wilms Tumor. 2024. https://www.medscape.com/.
  • PDQ® Pediatric Treatment Editorial Board. Wilms Tumor and Other Childhood Kidney Tumors Treatment (PDQ®) – Health Professional Version. Bethesda, MD: National Cancer Institute; 2025. https://www.cancer.gov/.
  • PDQ® Pediatric Treatment Editorial Board. Wilms Tumor (PDQ®) – Patient Version. Bethesda, MD: National Cancer Institute; 2025. https://www.cancer.gov/.

The kidneys

Wilms tumour starts in the cells of the kidneys. The kidneys are part of the urinary system. They make urine (pee) by filtering water and waste from the blood.

Other childhood kidney tumours

Other childhood kidney tumours include congenital mesoblastic nephroma, clear cell sarcoma and rhabdoid tumour.

Your trusted source for accurate cancer information

With support from readers like you, we can continue to provide the highest quality cancer information for over 100 types of cancer.

We’re here to ensure easy access to accurate cancer information for you and the millions of people who visit this website every year. But we can’t do it alone.

Every donation helps fund reliable cancer information, compassionate support services and the most promising research. Please give today because every contribution counts. Thank you.

Medical disclaimer

The information that the Canadian Cancer Society provides does not replace your relationship with your doctor. The information is for your general use, so be sure to talk to a qualified healthcare professional before making medical decisions or if you have questions about your health.

We do our best to make sure that the information we provide is accurate and reliable but cannot guarantee that it is error-free or complete.

The Canadian Cancer Society is not responsible for the quality of the information or services provided by other organizations and mentioned on cancer.ca, nor do we endorse any service, product, treatment or therapy.


1-888-939-3333 | cancer.ca | © 2026 Canadian Cancer Society